Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s stock price hit a new 52-week high during trading on Monday . The company traded as high as GBX 3.60 and last traded at GBX 3.30, with a volume of 4075231 shares traded. The stock had previously closed at GBX 3.02.
Cizzle Biotechnology Price Performance
The firm has a market capitalization of £13.08 million, a PE ratio of -19.41 and a beta of 0.51. The stock’s 50-day moving average price is GBX 2.06 and its 200 day moving average price is GBX 1.74.
Cizzle Biotechnology (LON:CIZ – Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported GBX (0.17) EPS for the quarter.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Featured Articles
- Five stocks we like better than Cizzle Biotechnology
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
